CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 Recruiting
452 enrolled
PSI-Immune
Phase 2 Recruiting
880 enrolled
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Phase 2 Recruiting
100 enrolled
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
Phase NA Recruiting
400 enrolled
INS-ESCC-CT
Phase 2 Recruiting
118 enrolled
STELLAR01
Phase 2 Recruiting
98 enrolled
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Recruiting
3,500 enrolled
Esophageal Cancer Risk Registry
Recruiting
7,000 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Phase NA Recruiting
420 enrolled
UDD
Recruiting
1,000 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions
Recruiting
50 enrolled
Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer
Recruiting
200 enrolled
A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring
Phase NA Recruiting
30 enrolled
CHANCES
Phase 1 Recruiting
27 enrolled
Volume Outcome Relationships and Effects
Recruiting
30 enrolled
REACH
Phase NA Recruiting
257 enrolled
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Phase 1 Recruiting
42 enrolled
ELEPHAS-04
Recruiting
324 enrolled
GENCONCOR-2
Recruiting
30 enrolled
Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy
Recruiting
5,000 enrolled
HEARTS Trial for Thoracic Cancers
Phase 2 Recruiting
60 enrolled
Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
Phase NA Recruiting
410 enrolled
PEGASUS
Phase 2 Recruiting
30 enrolled
Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)
Recruiting
1,500 enrolled
Retrospective Review of Esophageal Cancer at MSKCC
Recruiting
4,000 enrolled
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Phase 4 Recruiting
22 enrolled
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Phase 2 Recruiting
40 enrolled
A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
Phase 2 Recruiting
28 enrolled
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Recruiting
5,000 enrolled
MOMENTUM
Recruiting
8,000 enrolled
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 Recruiting
60 enrolled
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Phase NA Recruiting
600 enrolled
Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
22 enrolled
Endeavor-1
Phase NA Recruiting
50 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Recruiting
80 enrolled
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Recruiting
60 enrolled
MAGECmultiDiCE
Phase NA Recruiting
2,200 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
MAGEC
Phase NA Recruiting
1,000 enrolled
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Phase NA Recruiting
20 enrolled
VISTA
Phase 1 Recruiting
45 enrolled
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Phase 2 Recruiting
120 enrolled
OPTIMUS
Phase NA Recruiting
50 enrolled
POISE
Phase 3 Recruiting
20 enrolled
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Phase 2 Recruiting
49 enrolled
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Phase NA Recruiting
1,550 enrolled